These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6805547)

  • 1. The female carrier of Duchenne muscular dystrophy.
    Dubowitz V
    Br Med J (Clin Res Ed); 1982 May; 284(6327):1423-4. PubMed ID: 6805547
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the creatine kinase test in the detection of carriers of Duchenne muscular dystrophy.
    Thompson MW; Murphy EG; McAlpine PJ
    J Pediatr; 1967 Jul; 71(1):82-93. PubMed ID: 5293863
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA probes in Duchenne muscular dystrophy.
    Clayton J; Emery A
    Lancet; 1984 Nov; 2(8412):1151-2. PubMed ID: 6150202
    [No Abstract]   [Full Text] [Related]  

  • 5. Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy.
    Herrmann FH; Spiegler A; Wiedemann G
    Hum Genet; 1982; 61(2):102-4. PubMed ID: 7129438
    [No Abstract]   [Full Text] [Related]  

  • 6. Computed tomographic findings in manifesting carriers of Duchenne muscular dystrophy.
    de Visser M; Verbeeten B
    Clin Genet; 1985 Mar; 27(3):269-75. PubMed ID: 3987077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 8. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods.
    Tippett PA; Dennis NR; Machin D; Price CP; Clayton BE
    Clin Chim Acta; 1982 Jun; 121(3):345-59. PubMed ID: 7105400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier testing in families of isolated cases of duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity.
    Nicholson GA; Lane RJ; Gardner-Medwin D; Walton JN
    J Neurol Sci; 1981 Jul; 51(1):29-42. PubMed ID: 7252519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier detection in Duchenne muscular dystrophy.
    Nicholson GA; Gardner-Medwin D; Walton JN
    Lancet; 1979 Aug; 2(8138):367. PubMed ID: 89433
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic counselling in Duchenne and Becker muscular dystrophy is problematic when carrier studies give controversial results.
    Kääriäinen H; Lindlöf M; Somer H; de la Chapelle A
    Clin Genet; 1990 Mar; 37(3):179-87. PubMed ID: 1969777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of flanking markers in prediction for Duchenne muscular dystrophy.
    Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS
    Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of blind testing a method to detect carriers of the Duchenne muscular dystrophy gene.
    Monckton G; Zatz M; Mion CS; Marusyk H
    Am J Hum Genet; 1984 Jul; 36(4):926-30. PubMed ID: 6475962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier detection in Duchenne muscular dystrophy.
    Carter CO
    Lancet; 1979 May; 1(8123):979. PubMed ID: 87648
    [No Abstract]   [Full Text] [Related]  

  • 18. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in Duchenne muscular dystrophy: a review of current issues and approaches.
    Gruemer HD; Prior T
    Clin Chim Acta; 1987 Jan; 162(1):1-18. PubMed ID: 2879654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier detection and genetic counselling in Duchenne dystrophy.
    Dubowitz V
    Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.